| Fund ID | 805-9259798213 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 3% |
| Owned by funds of funds | 97% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| New Leaf Biopharma Opportunities II, L.P. | Venture Capital | $131.9M |
| New Leaf Ventures IV, L.P. | Venture Capital | $118.9M |
| New Leaf Ventures III, L.P. | Venture Capital | $100.5M |
Nlv Co-Invest IV, L.P. reports $16.8 million in gross assets, among the top 71% of private funds by size.
Nlv Co-Invest IV, L.P. is managed by New Leaf Venture Partners LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.